Clinical Trials Logo

Filter by:
NCT ID: NCT01837251 Completed - Clinical trials for Recurrent Platinum-sensitive Ovarian Cancer

Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Start date: May 2013
Phase: Phase 3
Study type: Interventional

Evaluation of the best therapeutic index for patients with platinum-sensitive ovarian cancer when treatment with bevacizumab and gemcitabine/carboplatin or with bevacizumab and PLD/carboplatin.

NCT ID: NCT01837186 Completed - Lung Cancer Clinical Trials

Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)

Start date: January 2012
Phase: N/A
Study type: Observational

Empyema following pneumonectomy for Non Small Cell Lung Cancer (NSCLC) is a known problem that occurs in about 2% of pneumonectomy patients.

NCT ID: NCT01836705 Completed - Neoplasm Malignant Clinical Trials

Effect of SAR302503 on ECG Activity in Patients With Solid Tumors

Start date: May 2013
Phase: Phase 1
Study type: Interventional

Primary Objective: - To assess the effect of SAR302503 (500 mg) administered as 14-day repeated doses on the QTcF interval compared to 1-day placebo in patients with advanced solid tumors. Secondary Objectives: - To assess the effect of SAR302503 administered as 14-day repeated doses on heart rate (HR), QT, QTcB, and QTcN, PR and QRS compared to placebo. - To assess the clinical and laboratory safety of SAR302503 - To document the plasma concentrations of SAR302503 at the time of ECG investigation. - To explore the Pharmacokinetic/Pharmacodynamic relationship between SAR302503 concentration and QTcF - To explore antitumor activity

NCT ID: NCT01836523 Completed - Diabetes Clinical Trials

The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

ADJUNCT ONEā„¢
Start date: November 2013
Phase: Phase 3
Study type: Interventional

This trial is conducted globally. The aim of the trial is to confirm the efficacy and safety of liraglutide as adjunct therapy to insulin in the treatment of type 1 diabetes. The total trial duration per subject is approximately 58 weeks.

NCT ID: NCT01836471 Completed - Asthma Clinical Trials

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

Start date: May 2013
Phase: Phase 2
Study type: Interventional

The purpose of the study is to assess the clinical effect of QAW039 in non-atopic asthmatics taking low dose Inhaled Corticosteroid (ICS) as background therapy.

NCT ID: NCT01835431 Completed - Diabetes Clinical Trials

A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

Start date: October 17, 2013
Phase: Phase 3
Study type: Interventional

This trial is conducted in Asia, Europe and North and South America. The aim of the trial is to investigate the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals in children and adolescents with type 1 diabetes mellitus.

NCT ID: NCT01834807 Completed - Clinical trials for Rheumatoid Arthritis

A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis

Start date: April 2013
Phase: N/A
Study type: Observational

This retrospective, observational, multi-center study will evaluate the use of biological agents (e.g. RoActemra/Actemra [tocilizumab]) in monotherapy in patients with rheumatoid arthritis. Data from medical record files will be collected of patients currently treated with a biologic in monotherapy.

NCT ID: NCT01834469 Completed - Ovarian Cancer Clinical Trials

Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients

OV-AP-ICG-IV
Start date: March 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if NIF fluorescent imaging is an effective approach to detect the gross ovarian tumoral tissues and peritoneal implants in Ovarian cancer patients.

NCT ID: NCT01833260 Completed - COPD Clinical Trials

Music and Perceived Rate of Exertion

Start date: May 2013
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the effect of listening to ambient music on the perceived exertion rate during pulmonary rehabilitation for chronic obstructive pulmonary disease patients.

NCT ID: NCT01832805 Completed - Clinical trials for Unipolar Major Depression

Theta Burst Study Ghent

TBS Ghent
Start date: April 2013
Phase: N/A
Study type: Interventional

50 Right-handed antidepressant-free unipolar depressed patients (age 18-65 years) will be treated with in total 20 Theta burst sessions; these will be spread over 4 days. On each stimulation day, a given patient shall receive 5 sessions with a between session delay of 10 to 15 minutes. Patients will be selected using the structured Mini-International Neuropsychiatric Interview (MINI). All will be at least stage I treatment resistant. Because concomitant antidepressant treatment can confound outcome results, all patients will go through a medication washout before entering the study and they will be free from any antidepressant, neuroleptic and mood stabilizer for at least two weeks before entering the treatment protocol. Only habitual benzodiazepine agents will be allowed. All patients will be closely matched for gender and age with 50 never-depressed medication-free healthy volunteers. Only baseline measurements will be collected: no volunteer will undergo the treatment. We expect that real Theta burst treatment and not sham will result in a significant and clinical meaningful response.